Week 2 Endocrine Flashcards

1
Q

A1C reduction with glucose

What is the gold standard?

A

Insulin

reduces A1C by about 2.5

Everything else about 1.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What drugs to use when compelling need to minimize hypoglycemia? (4)

A

DPP4
GLP1
SGLT2
TZD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Thiazolidinediones (2)*

A

Rosiglitazone (Avandia)

Pioglitazone (Actos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta-Adrenergic Antagonists

MOA

Common agents

AE

A

Acts by decreasing symptoms of adrenergic stimulation caused by T4 concentrations
Inhibits peripheral conversion of T4 to T3

Propanolol (non selective BB)

Decreased BP, bradycardia, cardiac arrest
CHF, Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Insulin Preparations

A

Rapid
Short
Intermediate
Long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Biguanides Old Contraindications*

A

Male Creatinine >/- 1.5mg/dL

Female Creatinine >/- 1.4mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What drug?

Direct acting (categorized based on duration after injection)

Major SE: Hypoglycemia

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes/Diagnoses of Hypothyroidism (3)

T4 concentrations
TSH concentrations

A

Hashimoto’s thyroiditis
Surgery
Meds (Lithium, RAI, Amiodarone)

Decreased total and free T4
Elevated TSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What insulin cannot be mixed with others?*

A

Long Acting*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Basal Insulin

Adults secrete about __ unit of insulin per ___ regardless of food intake

A

Secreted in small amounts throughout the day 50%

1 unit per hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DPP-4 Inhibitors

Adverse Effects

A

Well tolerated
Pancreatitis (rare)
Heart disease?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug?

Activates PPAR (steroid hormon) -> insulin sensitivity

Major SE: Peripheral edema, heart failure, bone loss, weight gain

A

Thiazolidinediones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Thioureas*

AE(3)

A

Rash
Fluid Retention
Decreased WBC** reverses on discontinuation if caught early

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of Therapy for Hyperthyroidism (3)

A

Surgery
Meds
Radioactive iodine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GLP-1 Agonists*

What is it?

A

Recombinant peptide that shares 53% of amino acid sequence w human GLP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SGLT 2 Inhibitors

Administration

A

Oral daily dosing

Dose must be adjusted for renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Canagliflozin (Invokana)

Dosing
Admin 
Renal Dose Adjustment 
Cost 
Patient Assistance
A
100-300mg daily 
Before first meal of the day
Yes
350$ for 30 tablets 
Available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DPP-4 Inhibitors CV Safety

A

Overall they were neutral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dapagliflozin (Farxiga)

Dosing 
Admin 
Renal Dose Adjustments 
Cost
Patient Assistance
A
5-10mg daily 
In the morning with or without food 
Yes 
$350 for 30 tablets 
Available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oral Combination Products a lot are combined with what drug?

A

Metformin

ie) Pioglitazone + Metformin, Glyburide + Metformin, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thiazolidediones

AE (2)
____ Risk
Pioglitazone recommended against use if you have

A

Hepatotoxicity, Edema
Fracture (reduces osteoblastic activity and increases urinary calcium excretion)
Bladder Ca or hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypoglycemia Picture of Sx

What do you do?

A
Shaky 
Fast Heartbeat 
Sweating 
Dizzy
Anxious 
Hungry 
Blurry Vision 
Weakness of Fatigue 
Headache
Irritable 

Check -> Tx -> Check

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thyroid Hormones effect (2)

A

Growth and Development

Maintain metabolic stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Short Acting Insulin (1)

A

Regular Humulin R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Biguanides New Contraindications*

A

GFR <30 = Contraindicated
GFR 30-45 = Do not start
GFR dips < 45 = Re-evaluate vs cut dose in half
GFR 30-60 with iodinated contrast = hold for 48 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Adverse Effects of Insulin* (4)

A

Hypoglycemia
Insulin Allergy
Immune Insulin Resistance
Lipohypertrophy (rotate injection sites)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

SGLT -2 CV Safety*

A

Significant CV reduction of residual CV risk!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

GLP-1 Agonists (4)*

A

Exenatide (Byetta)
Liraglutide (Victoza)
Albiglutide (Tanzeum)
Duglaglutide (Trulicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Rapid Acting Insulin (3)

A
Insulin Lispro (Humalog) 
Insulin Aspart (Novalog) 
Insulin Glulisine (Aventis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Levothyroxine*

Considered a “____”
Produces physiologic levels of?
Onset

A

Prodrug
T4 and T3
2-3 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What drugs to use when ASCVD predominates

A

1) SGLT2i*

2) GLP 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Bolus Insulin

Also called

Larger amounts secreted in response to food to

A

In response to food 50%

Premeal, mealtime, prandial, nutritional insulin

Decrease postprandial hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Duration of action of Insulin is ______ in pts with (2) failure

A

Prolonged

Hepatic and Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Intermediate Acting Insulin

Onset
Peak
Duration
\_\_\_ used for \_\_\_\_ IV use 
Usually administered 
Appearance*
A
2-4 hr 
4-8 hr 
8-12 hr 
NOT for emergency 
1-2 times/day 
CLOUDY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Glucagon

A

Secreted by a cells

Increases hepatic glucose output -> increases blood glucose concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Thioureas*

MOA

A

Inhibits iodination of tyrosine
Coupling of iodotryrosines

PTU also inhibits peripheral conversion of T4 to T3
DOES NOT effect release of preformed T4 and T3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Glipizide (2)*

Duration
Active Metabolite
Elimination

A

Glucotrol, Glucotrol XL

12-16 hrs
Inactive
90% Hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

GLP 1 Agonists*

AE (3)

A

N/V
HA
Pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Storage of Insulin*

A

Refrigerate if not in use
Room Temperature if in use/limit to 28 days

Away from direct heat or light

Check for clumps, frosting, failure to stay in suspension when mixed
Never use cloudy or discolored insulin except for NPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Meglitinides Potential Advantages

_____ onset and ____ duration of action
May be used in pts with ____ insufficiency
May be useful in pts who ___ meals

AE (2)

A

Rapid, short
Renal
Skip

Hypoglycemia
Weight Gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Diabetes Mellitus

A

A syndrome that develops when insulin secretion or activity are not sufficient to maintain blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Intermediate Acting Insulin (2)

A

NPH Humulin N

NPH Novolin N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

*Insulin Dose based on:

Type 2:
Type 1:

Observe for

A

Total Body Weight

0.2 u/kg/day
Depends

Trends in hypoglycemia and hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Comparison of Common Agents

Equvalent Glucocorticoid dose, Mineralcorticoid potency

1) Hydrocortisone
2) Cortisone
3) Prednisone
4) Methylprednisolone
5) Dexamethasone

A

1) 20, +2
2) 25, +2
3) 5, +1
4) 4, +1
5) 0.75, 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Levothyroxine Adverse Effects (4)*

A

HF
Angina (painful constriction of tightness)
MI
Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Short Acting Insulin

Onset 
Peak 
Duration 
Administered 
May be given 
Appearance
A
30 min 
2-3 hr 
4-6 hr 
30-45 min before a meal*
IV
Clear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Intermediate/Long Uses (2)

A

Basal insulin needs

Not to cover meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Thioureas (2)*

A

Propylthiouracil (PTU)

Methimazole (Tapazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

DM Type II

A

NIDDM
- results from insulin secretory defect and insulin resistance
RELATIVE lack of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Thyroid Hormone Synthesis and Release

A

Iodine + Tyrosine
Organification into T1 and T2
Coupling into T3 and T4
Secretion of T3 and T4 into circulation

T4 is solely secreted from thyroid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Gestational Diabetes

A

Onset or discovery of glucose intolerance during pregnancy

52
Q

Natural Thyroid Hormones
(____ Thyroid)

Dessicated (3) thyroid
Contains a ____ quanitity of T4 and T3
Bioavailability is ______
Allergies

A

Armour

Hog, Beef, Sheep
Standardized
Unpredictable

53
Q

Meglitinides

MOA

Onset
Peak
Duration
Metabolized

A

Same as sulfonylureas

15 min
60-90 min
< 4 hrs
CYP3A4

54
Q

DPP-4 Inhibitors (4)*

A

Sitagliptin (Januvia)
Saxagliptin (Ongylza)
Alogliptin (Nesina)
Lingagliptin (Tradjenta)

55
Q

What drugs to use when HF/CKD predominates

A

1) SGLT2i if eGFR is adequate

2) GLP-1

56
Q

Biguanides* (1)

A

Metformin (Glucophage)

57
Q

Medication-Induced Hyperglycemia

A
Thiazide diuretics 
Protease inhibitors 
Atypical antipsychotics 
Glucocorticoids 
Calcineurin inhibitors 
Nicotinic acid 
Oral Contraceptives 
Phenytoin
58
Q

Biguanides Contraindications*

Impairments (2)

Contraindications (4)

A

Renal Impairment*
Hepatic Impairment = may decrease ability to eliminate lactic acid*

Hypoxic states
Acute or chronic alcohol abuse
Elderly
CHF on drug therapy

59
Q

Long Acting Insulin (5)

A
Insulin Glargine (Lantus) 100n/mL
Insulin Glargine (Basaglar) 100u/mL
Insulin Glargine (Toujeo) 300u/mL
Insuline Detemir (Levemir) 
Insulin Degludec (Tresiba)
60
Q

DPP-4 Inhibitors

Administration

A

Once daily oral admin

Adjustment necessary for pts with renal dysfunction

61
Q

Combination Products* (3)

A
Novolin or Humulin 70/30
     - NPH 70% Regular 30%
Novolog 70/50
     - Aspart protamine 70% Aspart 30%
Humalog 50/50  75/25
     - Lispro protamine 50% 75% Lispro 50% 25%
62
Q

Adverse Effects of Insulin*

Hypoglycemia*  
Signs of autonomic \_\_\_\_\_\_
     - Sympathetic (4)
     - Parasympathetic (2) 
     - May progress to (2) if untreated
A

Hyperactivity

 - Tachycardia, Palpitations, Sweating, Tremulousness
 - Nausea, Hunger 
 - Seizures, Coma
63
Q

SGLT 2 Inhibitors*

Potential Advantages (4)*

A

Weight Loss (75g urine glucose = 300kcal/day)
Decrease risk of hypoglycemia
Lowers BP
Renal Protection

64
Q

Liothyronine* T3 Cytomel*

Higher incidence of?
Why is not really used?

A

Cardiac events
Difficulty monitoring w conventional lab tests
$$

65
Q

Biguanides*

Caution with: *

Advantages (3)

AE(2)

A

Iodinated Contrast*

No hypoglycemia when used as monotherapy
Weight loss
Decrease triglycerides

N/V/D
Metallic taste

66
Q

Insuline Detemir

Onset
Peak
Duration
Appearance

A

2 hr
3-9 hr
14-24 hr
Clear

67
Q

SGLT2 Inhibitors (3)*

A

Canagliflozin (Invokana)
Dapagliflozin (Farxiga)
Empagliflozin (Jardiance)

68
Q

Pharmacologic Agents (10)

A
Insulin 
Sulfonylureas
Meglitinides 
Biguanides 
a Glucosidase Inhibitors 
Thiazolidinediones 
GLP-1 Agonists 
DDP 4 Inhibitors 
SGLT 2 Inhibitors 
Amylin Agonists
69
Q

SGLT- The Bad

May 2016: All
June 2016: Canagliflozin
June 2016: Canag and Dapag
November 2016: All

A

Increased risk for DKA
Boxed warning for leg/foot amputations
Increased risk for acute kidney injury
Increased risk for bone loss

70
Q

Animal Insulin (2)

Human Insulin is produced through

Insulin is a ____ hormone that cannot be given ___

Circulating insulin has half life of only a few ___ dt rapid removal by (2)

A

Beef, Pork

Recombinant DNA Techniques

Peptide, PO

Minutes, Liver and Kidneys

71
Q

GLP 1 CV Safety

A

WE literally just wanted to prove it didn’t have cardiotoxic effects (thia)

But we found the opposite happened, not even just safety but they improved CV risk!

72
Q

Thyroid Hormones

A

T3 Triiodothyronine

T4 Thyroxine

73
Q

DPP Inhibitors*

MOA

A

Inhibits DPP-4 enzyme that is responsible for the breakdown on incretin hormones GLP-1

74
Q

Insulin Glargine

Onset
Peak
Duration
Appearance

A

4-5 hr
No peak
22-24 hr
Clear

75
Q

Tx of Adrenal Insufficiency

For Adrenal Crisis, Addisonian Crisis what do you use?

____ protein bound

Formulations (3)

A

Parenteral glucocorticoids

Highly

Oral: exhibits 100% absorption
IV: succinate
IM: acetate

76
Q

DM Complications

A
Blindness
Heart Attack 
Kidney Failure 
Stroke 
Dental Problems 
Amputation 
Pregnancy Complication 
Nerve Damage 
Sexual Dysfunction 
Insulin Injection
77
Q

Insulin

A

Secreted by B cells

Promote uptake utilization and storage of glucose -> lowers plasma glucose concentration

78
Q

Glyburide (3)*

Duration
Active Metabolite
Elimination

A

Diabeta, Glynase, Prestab

12-24 hrs
Inactive
50% Hepatic/50% Renal (the only one w renal excretion)

79
Q

DM Type I

A

IDDM

  • results from B cell destruction
  • ABSOLUTE lack of insulin
80
Q

What is an essential component of both T3 and T4

A

Iodine

81
Q

SGLT 2 Inhibitors*

Concerns

A
Limp amputation
Electrolyte disturbances
Decreased BP 
Bacterial urinary infections 
Fungal genital infections 
Malignancy
82
Q

Causes/Diagnosis of Hyperthyroidism (3)

T4 concentrations
TSH concentrations

A

Graves Disease
Thyroid stimulating antibodies
Meds (Amiodarone)

Elevated total and free T4
Suppressed TSH

83
Q

Empagliflozin (Jardiance)

Dosing 
Administration 
Renal Dose Adjustments 
Cost 
Patient Assistance
A
10-25mg daily 
In the morning with or without food 
Yes
TBD
TBD
84
Q

Administration*

1)
sites (3)
accelerates absorption (3)
types (3)

2)
What insulins are given by this route (2)

A

1) SubQ
Abdomen, Butt, Arms/Legs
Exercise, Rubbing, Heat
Vial and Syringe, Pens, Pumps

2) IV
Rapid and Short

85
Q

Sulfonylureas*

Metabolism and Excretion

A

Hepatically metabolized
- caution w hepatic impairment

Renally excreted
- Glyburide may accumlate in pts w CrCL < 30ml/min

86
Q

Portable Pen Injectors

A

Vials of insulin + replaceable needles
More accurate dosing mechanisms
Faster and Easier than conventional syringes
Increased patient compliance

87
Q

Incretin Mimetics

A

Food -> GLP 1 ->
Stimulates insulin release
Delays gastric emptying
Suppression of postpradial glucagon release

DPP-4 inhibits GLP 1

88
Q

Thiazolidinediones Contraindication*

A

May cause or exacerbate CHF*
Contraindicated in NYHA Class III or IV HF*
After initiation of dose, observe pts for s/s of HF

89
Q

Pancreatic Hormones (2)

A

Glucagon

Insulin

90
Q

Thioureas*

Well absorbed by the
___ is highly protein bound unlike ___ which is not significantly bound to protein
Both agents have ____ lives, however they
Patient becomes _____ over a 1-2 month period

A

GI
PTU, Methimazole
Short, accumulates in thyroid gland to exert longer effects
Euthyroid

91
Q

Sulfonylureas Adverse Effects*

A

Hypoglycemia (most common)*

Rash, Photosensitivity, Hypersensitivity

N/V, abnormal LFT’s

Weight Gain

92
Q

What drugs to use when compelling need to minimize weight gain or promote weight loss?

A

GLP 1

SGLT 2

93
Q

Secondary causes of DM (4)

A

Pancreatic Disease
Cystic Fibrosis
Endocrinopathies
Drugs and Chemicals

94
Q

Infusion Pump

A

Connected to subc catheter to deliver short acting insulin

Decreases glycemic variability

Does have logistical issues and is more expensive

95
Q

What drugs?

Promotes production of insulin when stimulated by food

Major SE: Pancreatitis

A

Incretins (GLP1 & DPP4 Inhibitors)

96
Q

Sulfonylureas

MOA

Secondary effects (2)

Therapeutic Use:

A

Increase secretion of preformed insulin by B cells by closing K+ channels

Increase insulin receptor sensitivity
Decrease hepatic glucose output

Type 2

97
Q

Biguanides*

MOA
Secondary effects

Therapeutic use

A

Decrease hepatic glucose output
Increases peripheral glucose uptake and utilization

Type 2 DM

98
Q

Thiazolidediones*

MOA + (3)

A

Binds to nuclear steroid hormone receptor and promotes glucose uptake into skeletal, muscle, and adipose tissue

  • Increases insulin sensitivity
  • Decreases insulin resistance
  • NO EFFECT ON INSULIN SECRETION*
99
Q

Iodine-Containing Compounds

MOA

Common Agents (2)

AE

A

Immediately inhibits release of T4 and T3

Lugols solution, Potassium iodide solutions (SSKI)

Rash, metallic taste, sore gums, GI discomfort, hypothyroidism

100
Q

Glimiperide (1)*

Duration
Active Metabolite
Elimination

A

Amaryl

24 hr
Weakly active
100% Hepatic

101
Q

Goals for Glycemic Control

1) A1C
2) Fasting Glucose
3) Peak postprandial glucose (1-2 hrs after meal)

A

1) <6.5-7.0%
2) 80-130
3) <180

102
Q

What drugs? (2)

Closes K+ channels -> insulin release

Major SE
Hypoglycemia, Weight Gain

A

Sulfonylureas

Meglitinides

103
Q

Liotrix (T4:T3 4:1) Thyrolar*

Why is not really used? (2)

A

No advantage over T4 alone

$$$$

104
Q

Drug of choice for thyroid replacement?*

Chemically ____
Expensive?
Free of ______

A

Levothyroxine

Stable
Inexpensive
Antigenicity

105
Q

Combination Products

Advantages

Disadvantages

A

Less injections/day
Less calculations by pt

Dose adjustments alter both products

106
Q

GLP 1 Agonists*

Precautions (2)

A

Not recommended in pts with CrCl <30 mL/min

Should not be used in pts with a personal or family hx of medullary thyroid cancer

107
Q

Synthetic Thyroid Hormones (3)*

A

Levothyroxine (T4, L-thyroxine, Synthroid, Levoxyl)

Liothyronine (T3 (Cytomel))

Liotrix (T4:T3 4:1) (Thyrolar)

108
Q

What drug?

Inhibits glucose reabsorption by kidneys, increase glycosuria

Major SE: Genitourinary infections, polyuria

A

SGLT 2 Inhibitors

109
Q

Meds to treat Hyperthyroidism (4)

A

Thioureas
Iodine-containing compounds
B-adrenergic antagonists
Corticosteroids

110
Q

Technosphere Insulin

Dry ___ of human ___ insulin formulated to absorb onto ____ microparticles for ____ admin

Peak ~ ___ min

Metabolism similar to ____ insulin

Administered when?

Black Box Warning:

A

First inhaled product the “Dreamboat”

Powder, rDNA, Technosphere, pulmonary

15

Regular human

Before or within 20 min of starting

Bronchoconstriction
NO USE w COPD, Asthma
Not recommended for patients who smoke

111
Q

Insulin Administration

A

SQ or IV

112
Q

What drug?

Decreases gluconeogenesis
Increases glyolysis

Major SE: Lactic acidosis, GI symptoms

A

Metformin

113
Q

What drugs to use when cost is a major issue?

A

SU

TZD

114
Q

DPP-4 Inhibitors

FDA Warning 2015

A

Severe Joint Pain

115
Q

Therapeutic Uses of Insulin

1) Type 1
2) Type 2
3) DM of ______

A

1) Therapy of choice
2) For those who cannot control with diet, exercise, oral meds OR newly diagnosed presenting with severe, symptomatic hyperglycemia
3) Pregnancy

116
Q

Sulfonylureas (3)*

2nd gen

A

Glyburide (Diabeta, Glynase, Prestab)

Glipizide (Glucotrol, Glucotrol XL)

Glimepiride (Amaryl)

117
Q

Tx of Hypoglycemia*

1) Mild Hypoglycemia + Conscious, Able to Swallow
2) Severe Hypoglycemia + Unconscious/Stupor

A

1) Simple sugar, glucose
(juice, hard candy, sugar packets/glucose gel, tablets)

2) 20-50ml Dextrose 50% IV or 1mg Glucagon SQ/IM

118
Q

GLP 1 Agonists*

How is it administered?
How often?

A

Pre-filled pens for subcutaneous injection

Once or twice daily to once weekly

119
Q

SGLT 2 Inhibitors

Drug interactions

A

No major interactions

120
Q

Rapid Acting Insulin

Onset
Peak
Duration 
Administered
Ideally added to \_\_\_ insulin regimen 
May be given 
Appearance
A
15-30 min
1-2 hr
3-4 hr 
Immediately before a meal*
Basal 
IV 
Clear
121
Q

____ channels determine resting membrane potential in __ cells

Glucose enters B cells via a membrane transporter __-__

KATP are blocked causing membrane _____ and opens ____ channels

Ca2+ signals ____ secretion

A

ATP Sensitive K+ (KATP)
B

Glut-2

Depolarization, Ca2+

Insulin

122
Q

SGLT 2 Inhibitors*

MOA

A

Inhibits sodium glucose transporter 2 in the proximal renal tubules -> reduces reabsorption of filtered glucose and increased urinary excretion of glucose

Thereby reducing plasma glucose concentrations

123
Q

Corticosteroids

MOA (2)

A

Decreases thyroid action

Suppresses immune response in Grave’s

124
Q

Insulin Dosing Pearls*

1 unit of insulin decreases blood glucose by:

Start ___ then ___ to meet nutritional needs

Wait ___ before adjusting dose

Insulin should never be stopped in:

A

50mg/dL (30-100)

low, increase

24 hrs

Type 1*

125
Q

The Role of the Adrenal Glands

3

A

Responsible for regulating stress response through synthesis of

1) Glucorticoids (cortisol)
2) Mineralcorticoids (Aldosterone)
3) Adrenal Androgens

126
Q

Non-Glycemic Goals

1) BP
2) LDL
3) Triglycerides

A

1) <130/80
2) <100, <70 CV disease
3) <150

127
Q

Rapid/Short Acting Uses (2)

A

Mealtime

Elevated Glucose